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Bovine Coronavirus (BCoV) is known to cause enteric and respiratory diseases, such as 
calf diarrhea, winter dysentery, calf respiratory disease, and bovine respiratory disease complex 
(BRD). All of these diseases are believed to be caused by the same genotype of BCoV. BCoV 
exhibits tissue tropism for both the gastrointestinal and respiratory tracts. This tropism is due to 
9-O-acetylated sialic acid receptor on both epithelial cells in the respiratory and enteric tract. 
Currently, the only vaccine available for BCoV targets the enteric form of the disease. This study 
addresses the hypothesis that antibodies from the enteric form of the disease can cross neutralize 
the respiratory form of the virus. Data from surveillance studies suggest that BCoV is one of the 
major contributors to BRD, for which there is no currently approved vaccine for the respiratory 
form of the disease. 
Our approach to answering this question is to sequence and analyze the complete genome 
of 11 respiratory and enteric coronavirus isolates using next generation sequencing (NGS). 
Following the NGS, viruses were selected based on phylogenetic analysis and ability to grow 
and be maintained in cell culture. These viruses were then be used as serum neutralization 
indicator viruses in SN assays. 147 bovine serums submitted to KSVDL were used to determine 
if there are any serological differences between the immune response to respiratory versus 
enteric viruses based on the antibodies produced by the animal. 
The overall results show that there are few differences between the enteric and 
respiratory isolates at the genomic level and the serological response from the animal to these 
viruses. The differences between enteric and respiratory virus will need to be further addressed 
and analyzed to conclude if there is a noteworthy difference between the viruses with different 
tropisms.  Other factors, such as host immune response and environment, are believed to be 
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Chapter 1 - Coronavirus Literature Review 
 Introduction 
Coronaviruses comprise a diverse group of large, enveloped, positive sense single 
stranded RNA viruses that belong to the family Coronaviridae. Coronaviruses are known to 
infect a wide variety of animals that range all the way from whales down to mice. They mainly 
cause enteric and respiratory disease in mammals and birds (Hurst et al., 2013) but have also 
caused hepatic and neurological diseases as well.(Cheng et al., 2007) While coronaviruses have a 
relatively low mortality rate, they can cause huge economic loss by a decrease in production 
standard of livestock and an increase in healthcare costs. (Martínez et al., 2012) A significant 
outcome of the research being done is the production of a vaccine for preventing bovine 
coronavirus enteric infections in calves. There has been some research that supports the use of 
the enteric vaccine in feedlot animals to minimize respiratory disease.(Plummer et al., 2004) 
However, very little is known regarding the tissue tropism of bovine coronavirus and the cross 
protection of antibodies to the two varieties 
of viruses. 
  History 
The first coronavirus to be identified was infectious bronchitis virus (IBV) that was found 
in chickens in 1932 and is now classified in the gamma-coronavirus genera. (Hudson and 
Beaudette, 1932) This was followed by the identification of mouse hepatitis virus (MHV) in 
1940 (Cheever et al., 1949) followed by transmissible gastroenteritis virus (TGEV) in pigs. 
(DOYLE and HUTCHINGS, 1946) In the 1960s human coronavirus 229E (HCoV 229E) and 
human coronavirus OC43 (HCoV-OC43) were identified in people with common cold 
symptoms. (Tyrrell and Bynoe, 1966), (Hamre and Procknow, 1966) In 1975, bovine 
coronavirus was identified as a major contributor to calf scours and was isolated and cultured to 
be used as a vaccine. (1975) By 2003, porcine hemagglutinating encephalomyelitis virus 
(PHEV), porcine epidemic diarrhea virus (PEDV), porcine respiratory coronavirus (PRCV), and 
feline coronavirus (FCoV) had been sequenced and their complete genomes were being studied. 
(Woo et al., 2009)  
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Within the last few years, coronaviruses have been gaining more attention due to the 
media coverage of the emerging human epidemics known as severe acute respiratory syndrome 
(SARS) and Middle East respiratory syndrome (MERS). The SARS outbreak in 2002, was the 
first coronavirus to cause severe disease in humans and gain the media’s attention. Investigators 
believe that the source came from human exposure to exotic wild-game animals in live markets. 
(Hilgenfeld and Peiris, 2013) The repeated exposure led to interspecies transmission of the 
coronavirus and then to the human outbreak itself. After the SARS epidemic, research on 
coronaviruses increased and more complete genomes of different species were added.  In 2012, 
another novel coronavirus was emerging as many elderly and immunocompromised patients in 
the Middle East were reporting respiratory illness. (Zaki et al., 2012) While viruses detected in 
bats are closely related to MERS, investigators believe that the transmitter of the virus was the 
dromedary camel.(Hilgenfeld and Peiris, 2013)  
Today research strives to understand more about the mechanisms of replication with an 
emphasis on the explanation of the molecular factors of virulence and tropism and how the virus 
interacts with the host’s immune response. There is also research going to improvement of 
vaccine approaches and antiviral therapies for animal and human viruses. Lastly, research is 
looking ahead to the potential of isolation and characterization of new coronaviruses (Weiss and 
Navas-Martin, 2005). 
 Family Coronaviridae 
Coronaviruses are classified by the International Committee on Taxonomy of Viruses  
(ICTV) as part of the order Nadovidovirales and family Coronaviridae. The family 
Coronaviridae includes some of the larger RNA viruses with genomes ranging from 26.2 to 
31.7kb and sizes ranging from 80 to 160 nm.(Belouzard et al., 2012) (Perlman and Netland, 
2009) The circular viral envelope is studded with spikes giving coronaviruses their characteristic 
crown appearance. (Fields, et al., 2001) Coronaviruses are classified in four different genera 
based on serological and phylogenetic analysis: alpha-, beta-, gamma-, and delta-coronavirus. 
(Belouzard et al., 2012) Figure 1.1 shows the phylogenetic tree of these different genera. The 
diversity of these groups comes from the large genome of coronaviruses, random template 




Alphacoronavirus genus is broken into two subgroups, 1a and 1b, based on phylogenetic 
clustering. While viruses in group 1a demonstrate genetic similarities to each other, group 1b is 
more diverse are simply grouped as “non-group 1a”. Group 1a includes TGEV, PRCV, FCoV, 
canine enteric CoV, ferret CoV, and rabbit CoV. Group 1b includes HCoV-229E, HCoV-NL63, 
PEDV, BtCoV/512/2005, BtCoV-HKU2, BtCoV-HKU8, BtCoV1A, and BtCoV1B.(Woo et al., 
2009) A unique characteristic of alphacoronaviruses is that they have two papain-like proteases 
in their genome which are used to cleave proteins.(Woo et al., 2009) 
Betacoronavirus genera is the largest genera of coronaviruses and has subgroups 2a, 2b, 
2c, and 2d. Bovine coronavirus is part of the 2a subgroup (Enjuanes et al., 2006) along with 
human coronavirus OC43(HCoV-OC43), equine coronavirus (ECoV), porcine hemagglutinating 
encephalomyelitis virus (PHEV), mouse hepatitis virus (MHV), human coronavirus HKU1 
(HCoV-HKU1), canine respiratory CoV and rat CoV. (Decaro et al., 2008) (Bidokhti et al., 
2013) The subgroup 2a is unique because the genomes contain a hemagglutinin esterase protein 
that aids the virus in attachment. Also like subgroup 1, 2a has two papain-like proteins for 
cleaving proteins(Woo et al., 2009). Subgroup 2b includes the human SARS-CoV and bat SARS 
CoV. The third subgroup, 2c, includes the MERS-CoV, Bt-CoV-HKU4, and Bt-CoV-HKU5. 
The last subgroup, 2d, only has one member and that is Bt-CoV-HKU9.4.(Graham et al., 2013) 
Betacoronaviruses are notorious for homologous and heterologous recombination events within 
the group. This has led to the generation of various genotypes and strains within the coronavirus 
species.(Woo et al., 2009)(Lai et al., 1985) 
For 50 years the only species in Gammacoronavirus was IBV but within the last 10 years 
other avian and mammal viruses have been added: turkey-CoV, duck-CoV, geese-CoV, pigeon-
CoV, pheasant-CoV, and beluga whale coronavirus (SW1) which has the largest genome (32kb).  
Recently, a novel genus, Deltacoronavirus, has been added and three coronaviruses 
moved from Gammacoronavirus into this genus: Bulbul coronavirus (BuCoV-HKU11), Thrush 
coronavirus (ThCoV- HKU12) and Munia coronavirus (MuCoV-HKU13) which have the 
smallest coronavirus genome (around 27 kb). (Woo et al., 2009) (Woo et al., 2012) 
Coronaviruses newly added to this genus include the night heron-CoV, magpie robin-CoV, 
common moorhen-CoV, sparrow-CoV, wigeon-CoV, and white eye-CoV. They also have 




Figure 1-1 Coronavirus Whole Genome Phylogenetic Tree 
The full genomic sequences of 46 coronaviruses were aligned and phylogenetically compared, 
based on the table below. Four distinct phylogenetic groups are shown: alphacoronavirus, 
betacoronavirus, gammacoronavirus, and deltacoronavirus. Subgroups for alphacoronavirus are 
indicated by 1a and 1b. Subgroups for Betacoronavirus are indicated by 2a, 2b, 2c, and 2d. This 
tree was generated using maximum likelihood in CLC Main workbench. 
Genera Abbreviation Name 
Alphacoronavirus 1a FCoV Feline coronavirus 
 TGEV Transmissible gastroenteritis virus 
 PRCV Porcine respiratory coronavirus 
 Canine.ent.CoV Enteric canine coronavirus 
Alphacoronavirus 1b Bt.CoV.HKU2 Bat coronavirus HKU2 
 H.CoV.NL63 Human coronavirus NL63 
 H.CoV.229E Human coronavirus 229E 
 PED Porcine epidemic diarrhea virus 
 Bt.CoV.512.2005 Bat coronavirus 512 
 Bt.CoV.HKU8.AFCD77 Bat coronavirus HKU8 
 Bt.CoV.1A.AFCD62 Bat coronavirus 1A.AFCD62 
 Bt.CoV.1B.AFCD307 Bat coronavirus 1B.AFCD307 
Betacoronavirus 2a H.CoV.HKU1 Human coronavirus HKU1 
 MHV Mouse hepatitis virus 
 PHEV Porcine hemagglutinating encephalomyelitis virus 
 H.CoV.OC43 Human coronavirus OC43 
 BCoV Bovine coronavirus 
 Rat.Cov Rat coronavirus 
 Equine.CoV Equine coronavirus 
 Canine.resp.CoV Respiratory canine coronavirus 
 Rabbit.CoV Rabbit coronavirus 
Betacoroanvirus 2b H.SARS.CoV Human SARS coronavirus 
 Bt.SARS.CoV.HKU3 Bat SARS coronavirus HKU3 
 Bt.SARS.CoV.RP3 Bat SARS coronavirus RP3 
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 Bt.SARS.CoV.RF1 Bat SARS coronavirus RF1 
 Bt.SARS.CoV.RM1 Bat SARS coronavirus RM1 
Betacoronavirus 2c Bt.CoV.HKU5 Bat coronavirus HKU15 
 Bt.CoV.133.2005 Bat coronavirus 133 2005 
 Bt.CoV.HKU4 Bat coronavirus HKU4 
 H.MERS.CoV Human MERS coronavirus 
Betacoronavirus 2d Bt.CoV.HKU9 Bat coronavirus HKU9 
Gammacoronavirus IBV Avian infectious bronchitis virus 
 Turkey.CoV Turkey coronavirus 
 Duck.CoV Duck coronavirus 
 SW1.CoV Beluga whale coronavirus 
Deltacoronavirus Bulbul.CoV Bulbul coronavirus 
 Thrush.CoV Thrush coronavirus 
 Munia.CoV Munia coronavirus 
 AsianLepordCat.CoV Asian lepord cat coronavirus 
 NightHeron.CoV Night heron coronavirus 
 Magpie.CoV Magpie coronavirus 
 Moorhen.CoV Moorhen coronavirus 
 Sparrow.CoV Sparrow coronavirus 
 Wigeon.CoV Wigeon coronavirus 










 Bovine Coronavirus 
Bovine coronavirus is wide spread throughout cattle in the United States. Infection by 
BCoV can result in a loss of body condition of the animal which can then lead to decreased milk 
production and death in young animals. (Saif, 2010) Consequently, this severely impacts the 
economics of the cattle industry. BCoV is a pneumoenteric virus that infects both the upper and 
lower respiratory tracts as well as the intestine, and is therefore, shed in feces and nasal 
secretions. Bovine Coronavirus causes 3 distinct clinical syndromes in cattle: calf diarrhea, 
winter dysentery with hemorrhagic diarrhea in adults, and respiratory infections in cattle of 
various ages and is also included the bovine respiratory disease complex, or shipping fever, that 
is seen in feedlot cattle. The clinical appearance of the disease is not solely related to the virus 
itself but also to the host and environmental factors. No consistent antigenic or genetic markers 
have been identified to discriminate BCoVs isolated from animals presenting the different 
clinical syndromes. At present, there are no BCoV vaccines to prevent respiratory BCoV 
infections in cattle, and the correlates of immunity to respiratory BCoV infections are unknown. 
(Saif, 2010)  
 
 Genomic Organization 
The coronavirus genome is a long, flexible, positive-stranded RNA that is encapsulated 
by the nucleocapsid protein which gives the genome its structure.(Fields, et al., 2001) The 
genome is composed of six open reading frames (ORFs). The first ORF comprises two-thirds of 
the genome and encodes the replicase proteins. The last third of the genome encodes the 
structural proteins in a fixed order: (HE)-S-E-M-N. HE is the hemagglutinin esterase which is 
responsible for neuraminate O-acetyl-esterase activity and is only found in members of 
betacoronavirus subgroup 2a. The virion envelope contains three additional viral proteins, the 
spike protein (S), the membrane protein (M) and the envelope protein (E). The M and E proteins 
are involved in virus assembly, while the spike protein is the leading mediator of viral entry and 
accounts for a lot of the diversity in bovine coronavirus.  The nucleoprotein (N) is the last of the 





Figure 1-2 Bovine Coronavirus Genome Organization 
Genome organization of Bovine coronavirus (NC_003045). PL1, papain-like protease 1; PL2, 
papain-like protease 2; 3CL, chymotrypsin-like protease; Pol, RNA-dependent RNA polymerase; 
Hel, helicase; HE, hemagglutinin esterase; S, spike; E, envelope; M, membrane; N, 
nucleocapsid. 
 
 Viral Proteins 
 Nonstructural Proteins 
The nonstructural proteins of BCoV are highly conserved and make up 2/3 of the 
genome. The first nonstructural protein that is synthesized is the polymerase precursor 
polyprotein 1a and 1b. It is directly produced form the viral genome because its function in viral 
RNA synthesis. The precursor polyprotein is processed to make RNA-dependent RNA 
polymerases (Pol) which will transcribe the genome to the subgenomic mRNAs. The rest of the 
nonstructural proteins are synthesized from 7 subgenomic mRNAs. The next nonstructural 
proteins come from ORF 1a and are papain-like protease (PLP) and chymotrypsin 3C-like 
protease (3CL). Alpha-coronavirus and beta-coronavirus in subgroup A, including bovine 
coronavirus, have two PLPs. Their function is to cleave the polyprotein into multiple smaller 
proteins. Following Pol is the helicase protein that unwinds the genomic RNA for transcription. 
(Fields, et al., 2001) (Woo et al., 2010) 
  Hemagglutinin Esterase 
Hemagglutinin esterase is a disulfide linked dimer that forms the short spikes on the 
virus.(Fields, et al., 2001) It is believed to come from the influenza C-like HE fusion protein 
through lateral gene transfer, therefore, has a similar function that involves receptor binding and 
detachment.(Hasoksuz et al., 2002a) Like the spike protein, HE binds to 9-O-acetylated 
neuraminic acid residues. (Fields, et al., 2001) HE is only found in the members of 
betacoronavirus subgroup A which includes human, murine, and bovine coronavirus. (Hasoksuz 
et al., 2002a)(Woo et al., 2010) While it is not necessary for viral replication, it is considered a 




The variations in host range and tissue tropism comes from the spike protein. The S 
protein is mainly used for receptor binding and viral entry into the cell.(Woo et al., 2010) This 
type 1 glycoprotein is 1363 amino acids long and assembles into trimmers on the surface giving 
the virus a “corona”, or crown-like, appearance. The spike protein is comprised of three 
structural domains: a large terminal domain that is further broken into the S1 and S2 domains, 
and a transmembrane domain. The S1 and S2 domains are cleaved during virus maturation by the 
cellular protease. The cleaved subunits remain noncovalently associated in the viral spikes. 
(Fields, et al., 2001) The S1 is responsible for receptor binding and its sequence is more variable 
than S2. The S1 has two subdomains, N-terminal and C-terminal, which are both capable of 
binding to proteins or sugars. (Belouzard et al., 2012a) (Bidokhti et al., 2013) Mutations in the 
S1 region have been associated with changes in pathogenicity and antigenicity. (Martínez et al., 
2012) The S2 subunit is responsible for fusion of the viral and cellular membranes and is the 
more conserved region of the protein. (Belouzard et al., 2012a)  
 Envelope and Membrane 
The E and M proteins are small transmembrane proteins that aid in viral morphogenesis, 
assembly, and are essential for budding of virion. They are also highly conserved throughout all 
coronaviruses.(Woo et al., 2010)(Fields, et al., 2001) 
There is evidence that the M protein has two conformations: an elongated form and a 
compact form. The elongated form (MLONG) has a ridged structure with very little curvature and 
has a higher density of spike proteins. Conversely, the compact form (MCOMPACT) is more 
flexible and allows for more curvature of the virus and has fewer clusters of the spike proteins. 
These two different forms combined give the coronavirus its circular shape. (Neuman et al., 
2011) 
 Nucleocapsid 
The nucleocapsid protein is a highly conserved region found on the interior of the viral envelope 
and is responsible for wrapping the genomic RNA into its structure. It is shown that the 
nucleocapsid protein plays a key role in RNA synthesis by stabilizing and giving structure to the 




Bovine coronavirus uses the S2 subunit of the spike protein to interact with the 9-O-
acetylated sialic acid receptor which is located on a wide range of mammalian tissues. (Klein et 
al., 1994) This particular receptor is also used by influenza C and by HCoV-OC43 which is a 
human strain of coronavirus that caused upper respiratory infections before the SARS epidemic. 
(Perlman and Netland, 2009) (Herrler et al., 1991) Once it attaches to the receptor the virus is 
incorporated via endosome that is acidified by proton pumps. It is still unclear how the virus 
uncoats itself. (Fields, et al., 2001) When a coronavirus first infects a cell, it releases RNA that is 
structurally comparable to eukaryotic RNA. Researchers believe that this helps the virus take 
control over host cell machinery to translate the viral RNA. 
 First, the RNA polymerase precursor polyprotein 1a and 1b are synthesized from the 
viral genome because they are needed for synthesis of the remaining viral RNA. The rest of the 
viral proteins will be translated form subgenomic mRNA. These subgenomic mRNAs will 
correspond with one or more proteins. The viral replication complex aids in the transcription 
replication of the mRNA to proteins. The other proteins that are in ORF1a and 1b are PLP 
(papain-like cysteine protease), 3CL (chymotrypsin 3C-like protease), Pol (predicted 
polymerase), Hel (helicase), and MP (membrane-binding domain). The first step of virus 
assembly occurs when synthesized N proteins begin to form its core structure. Once the 
nucleocapsid is made, it interacts with the M protein at the endoplasmic reticulum or the Golgi 
complex. This interaction is believed to make the round internal core that surrounds the 
nucleocapsid. The N protein acts as a chaperone protein to aid in template switching. This slows 
host protein synthesis and increases viral protein synthesis. (Enjuanes et al., 2006)The major 
protein that aids in the formation of virus particles is the E protein. Without the E protein, the 
virus would have an altered virus morphology and could become noninfectious. The interaction 
of the E and M protein triggers virus budding. Budding usually occurs in the budding 
compartment that is located where the M protein is anchored. This is where the virus coats itself 
in the host’s membrane. Virologists believe that the E protein is then responsible for pinching off 
the budding virion in the budding compartment and can also cause apoptosis to certain cells 
(Enjuanes et al., 2006). The HE and S proteins are incorporated into the virion via interactions 
with the M protein. Once the virus has finished assembling, it will fuse with the plasma 
membrane to release the virus. The release of mature virus particles is restricted to a specific part 
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of the cell membrane but why there is site restriction is unknown. (Fields, et al., 2001)(Lai and 
Cavanagh, 1997)(Stadler et al., 2003) Figure 1.3 shows a diagram of the coronavirus replication 
within the host cell. 
 
Figure 1-3 Viral Replication 
Bovine coronavirus infects multiple cell types, the most common being epithelial cells. The steps 
in the virus life cycle are as follows. 1) Attachment of the virus to the 9-O-acetylated sialic acid 
receptor on the host cell surface. 2) Incorporation into the cell occurs via the endosome and then 
is acidified by proton pumps. 3) It is unclear how the virus uncoats itself but the positive sense 
single stranded RNA genome is released and RNA-dependent RNA polymerase is synthesized. 
4) The RNA-dependent RNA polymerase transcribes the positive sense RNA to negative sense 
RNA copies. 5) The negative sense RNA gets translated into proteins. 6) The formed 
nucleocapsid interacts with the M protein that will then trigger the virus surrounding itself in the 
host cell membrane 7) The virus begins to assemble in the Golgi Complex. 8) Once the virus has 





 Transmission and Pathogenesis 
Transmission of BCoV is horizontal with nose to nose interaction or through the oral-
fecal route. To a lesser extent it may also be passed by respiratory routes via aerosol. There is 
also some data to support that dogs may play a role in spreading BCoV because canine 
respiratory coronavirus is genetically similar to BCoV. (Kaneshima et al., 2007) Since 
coronaviruses are enveloped, they are less stable in the environment than non-enveloped proteins 
and cannot remain infectious unless protected. However, if protected by organic material, the 
virus will remain infectious for a brief period of time. It is believed that the virus begins 
replicating in the epithelial cells of the upper respiratory tract and then moves to the enterocytes 
of the gastrointestinal tract.(Boileau and Kapil, 2010) Bovine coronavirus is able to survive the 
gastrointestinal tract because it is very resistant to the host’s proteases. When growing BCoV in 
vitro you add trypsin to enhance virus infectivity. (Thomas et al., 2006) An infection with BCoV 
will induce fusion of the cells of infected tissues and eventually the lysis of cells.(Fields, et al., 
2001) Lysis of the cells initiates an immune response that is responsible for the symptoms that 
we observe in these infected animals. 
 Host Immune Response 
Most of what is known about the host’s response to coronavirus infection has been 
determined by studies involving the mouse hepatitis virus (MHV) and SARS coronavirus. The 
innate immune response of the host is crucial to determining the initial virus replication and the 
viral load the host must overcome. Once the virus enters and infects the host cell, it will take 
control of the cell’s machinery and begins replication. This will trigger a number of responses 
within the host. One of the responses is stimulation of both apoptotic and antiapoptotic 
molecules (Tang et al., 2005). The antiapoptotic stimulation allows for the cell’s survival while 
rapid viral replication takes place before the cell lysis occurs (Leung et al., 2003). The apoptotic 
stimulation is cell specific, such as T cells, and may be responsible for the pathology of 
infection.(Chau et al., 2004) Lysis of the host’s cells initiate a cascade of immunological 
responses that include inflammation and increased regulation of cytokines such as interleukin 8 
(IL-8) and interferon alpha/ beta (INFα/β). The release of IL-8 induces chemotaxis and 
phagocytosis to the infected area. INFα/β, named for its ability to interfere with viral replication, 
activates immune cells and increases the major histocompatibility complex (MHC) expression on 
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cells. Recruitment of the adaptive immune system is also critical for virus clearance. Dendritic 
cells and other antigen-presenting cells (APCs) present pieces of destroyed virus to the B-cells in 
circulation and in the lymph nodes. B-cells that have a strong affinity for an epitope of the virus 
will begin producing antibodies with the help of CD4 T-cells. CD8 T-cells will also be activated 
and search to induce apoptosis to any abnormal cells. The production of neutralizing antibodies 
has been shown to correlate with protection and severity of disease symptoms (Thomas et al., 
2006)(Cho et al., 2001). The adaptive immune response takes time to react after initial infection 
which allows the virus more time to replicate. As the virus replicates and the number of 
infectious particles increases, and excretion of the virus particles begins. This is called virus 
shedding and is shown to be the highest around day 4 after infection. (Hasoksuz et al., 2002) In 
BCoV, virus is shed primarily though the nasal secretions and fecal matter. In healthy animals 
the immune system will be activated and begin clearing the virus and will recover normally. 
Memory B-cells will also be generated in case the host comes in contact with the virus again so 
the adaptive immune response can react more rapidly. In immunocompromised or stressed 
animals, the immune system won’t be able to keep up with the viral load and the severity of the 
disease can increase. 
Younger animals do not have a developed immune system and that’s why lactogenic 
immunity is key to them fighting off disease. The first round of immunity from the mother is in 
the colostrum. The colostrum is full of antibodies that the calf will absorb. Within a few hours 
gut closure will take place and the calf will be unable to absorb the antibodies. The second round 
of immunity happens after gut closure. A few antibodies will still remain in the milk and will 
coat the villi of the gastrointestinal tract of the young animal and will be able to neutralize 
viruses before they can invade the villi epithelium.(Saif and Smith, 1985) 
 Diseases 
Bovine coronavirus was first identified as a primary pathogen that was responsible for 
neonatal calf diarrhea, or calf scours.(Mebus et al., 1973) Calf diarrhea coronavirus infection of 
the small and large intestine in calves causes destruction of the absorptive intestinal villous 
epithelial cells, leading to profuse watery diarrhea and loss of absorptive and digestive capability 
of the intestinal tract. Clinical symptoms include a yellow to blood-stained mucus-containing 
diarrhea which progresses to watery diarrhea.  Infected animals can become dehydrated, 
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depressed, weak, and hypothermic as well as develop acidosis and electrolyte abnormalities due 
to the loss of fluid in the feces and the fermentation of undigested nutrients which leads to 
bacterial overgrowth. (Ewaschuk et al., 2004) In extreme cases animals may develop pyrexia, 
recumbency, coma, and death if left untreated (Mebus et al., 1973).  
Winter dysentery is an acute, highly contagious gastrointestinal disorder that affects 
housed adult dairy cattle primarily during winter. Clinical signs include dysentery, a profound 
drop in milk production, variable anorexia and depression, and mild respiratory signs such as 
coughing.(Campbell and Cookingham, 1978) The disease has a high morbidity but low 
mortality, and spontaneous recovery within a few days is typical. BCoV is transmitted via the 
fecal-oral route through ingestion of feed or water contaminated with feces from clinical cases or 
clinically healthy carrier animals. Transmission of disease is promoted by close confinement. 
Winter dysentery is highly contagious and easily introduced to barns by carrier animals and 
fomites. Winter dysentery is common in northern climates where animals are housed indoors for 
extended periods during the winter months. (Van Kruiningen et al., 1985) Destruction of 
epithelial cells in the colonic crypts results in transudation of extracellular fluid and blood, 
explaining the hemorrhagic nature of the diarrhea in some cases.  
Lastly, bovine coronavirus is also linked with respiratory infections and is associated 
with bovine respiratory disease complex (BRDC), or shipping fever. Other microorganisms that 
are a part of BRDC include bovine respiratory syncytial virus, parainfluenza-3 virus, bovine 
herpesvirus, bovine viral diarrhea virus, as well as Mannheimia haemolytica serotype 1, and 
Pasteurella multocida.(Storz et al., 2000) There have been respiratory disease outbreaks where 
BCoV has been isolated without any detection of other respiratory viruses, bacteria, or 
mycoplasmas (Decaro et al., 2008). This indicates that BCoV may be a primary respiratory 
pathogen and active player in the BRDC. The clinical signs of infection are dyspnea, fever, 
coughing, weight loss, and, in more severe cases, pneumonia or even death. The respiratory 
disease may be more severe when the infection is combined with other factors such as 
environmental or host stresses or coinfections with other viruses or bacteria. 
 Detection and Quantification 
Some of the most common methods for detecting BCoV are PCR and assays involving 
immunofluorescence. PCR is used to detect the amount of viral genomic information present in a 
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sample. (Reynolds et al., 1984) This technique is helpful for things such as cloning or 
sequencing. The disadvantage to this method is being unable to determine if the virus has the 
ability to infect and replicate properly within the cell. The other most common approach is using 
fluorescent antibody assays. These types of assays are very valuable because you can use them 
for the detection of antigen and antibody. One example is an immuno-fluorescent assay (IFA). 
(Reynolds et al., 1984) By using a monoclonal antibody, this test method allows for a very 
specific detection of the virus and the approximate amount of infectious cells are present. The 
problem with this type of assay is that it requires highly specific antisera and a way to read the 
fluorescence.  In addition, false negative results can arise from the presence of blocking 
antibodies in the sample. (Athanassious et al., 1994)  
An alternative common option is an enzyme linked immunosorbent assay (ELISA). 
These come in many arrangements but the principle is similar to the IFA. ELISAs can also be 
used for antibody detection or antigen detection. This assay uses monoclonal antibodies to attach 
to an epitope of the virus and then uses either fluorescence or a color enzyme tagged antibody to 
show a positive result. Another option for detecting BCoV is using an electron microscope. The 
characteristic appearance of the spike protein allows for identification of the virus. The 
drawbacks to this method include risk of damage to the viral surface structures due to improper 
collection and/or transport of the sample, the presence of other viral particles or membranous 
structures which can be mistaken for coronavirus, and false negative results due to the disruption 
of coronavirus particles (Athanassious et al., 1994). 
 Control and Prevention 
Currently, the most effective protection from BCoV are commercial vaccines and proper 
management. Treatment of BCoV include supportive therapies such as reducing stress and 
replacing lost body fluid and electrolytes. Since a viral infection can lead to a secondary bacterial 
infection, antibiotic therapy can be administered. Other treatments are based on additional 
symptoms observed, which may include acidosis and hypoglycemia. 
 Vaccine 
The first and only strained used to make the vaccines in the U.S. against bovine 
coronavirus was patented in 1975 by Dr. Charles A. Mebus. The vaccine was prepared by 
passing infectious coronavirus in fetal bovine kidney cells to attenuate the virus which was then 
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grown to 102 to 106 TCID50 per dose. The production of this vaccine is still used for neonatal calf 
diarrhea. (1975)  Today, two types of vaccines still use this 40-year-old strain of virus. The first 
is a modified live rotavirus/coronavirus vaccine that is administered orally to calves at birth. The 
other is a killed vaccine which that includes a killed Escherichia coli bacterin and is given to late 
pregnant cows to give passive immunity to their calves. (Radostits, 1991)(Boileau and Kapil, 
2010) According to the National Animal Health Monitoring System (NAHMS), vaccination for 
coronaviruses are very low. In calves 1- 21 days old only 0.9% are vaccinated against 
coronavirus. In calves 22 days to weaning only 0.2% are vaccinated. Before breeding in heifers 
only 1.3% are vaccinated and after breeding and before calving 4.8% are vaccinated. In adult 
cows, 5.3% are vaccinated. (2009) There is currently no vaccine licensed specifically for use 
against the respiratory form of the disease, but there is some data indicating that the vaccine 
strain is protective against respiratory coronavirus as well. (Plummer et al., 2004) 
 Purpose of Research 
Bovine coronavirus exhibits tissue tropism for both the gastrointestinal and respiratory 
tracts. Currently, the only vaccine available for BCoV is derived from a 40-year-old enteric 
strain and targets only that form of the disease. It us unknown if this vaccine is still relevant for 
the enteric form of the disease and it has not been approved for respiratory coronavirus. The 
primary goal of this project is to establish a serological profile to the different genotypes of 
BCoV using virus serum neutralizations assays.  Serological relationship will be established by 
doing surveillance analysis on samples sent to the KSVDL to look at genetic relatedness as well 
as the time of year, gender of the animal, age, and if they are dairy or beef animals. 
 
Chapter 2 - Materials and Methods 
 Cells 
Human rectal tumor cells (HCT-8), were obtained from ATCC. They were used to isolate and 
amplify the bovine coronavirus isolates used in this project. (Hofmann et al., 1990) The cells 
were grown in a 37°C incubator using growth media composed of Minimum Essential Media 
(MEM) (Hyclone) containing 7% Fetal Bovine Serum (Hyclone), 29.2 mg/mL L-glutamine 
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(Hyclone), 10000 µg/mL each of Penicillin/Streptomycin (Hylocne), 250µg/mL Amphotericin B 
(Fisher), 10 µg/mL Ciprofloxacin (Mediatech). 
 Viruses used for SN Testing 
Enteric and respiratory viral isolates were obtained though clinical samples submitted to 
the Kansas State Veterinary Diagnostic Lab. (KSVDL accession #13-149008, 13-149100, 10-
78481, 14-007320 calf 1) Viral isolation was done on these samples and they were maintained in 
cell culture to be used as SN indicator viruses. The Mebus strain of bovine coronavirus was 
obtained from the National Veterinary Services Laboratories. The virus was carried an additional 
5 passages. When infecting cells, viral infection media composed of MEM with 29.2 mg/mL L-
glutamine, 10000 µg/mL each of Penicillin/Streptomycin, 250µg/mL Amphotericin B, and 
10µg/mL Ciprofloxacin was used. 
 Infectivity Titers 
96-well plates seeded with HCT-8 cells were maintained with MEM growth media for 4 
days. The cells were washed twice with sterile phosphate buffered saline (PBS) then inoculated 
with MEM viral isolation media that contained 0.05% trypsin and virus that was diluted in 10-
fold dilutions. After a 4-day incubation, the cells were fixed in 80% aqueous acetone for 10 
minutes. A dilution of 1:100 primary hybridoma antibody in a 1:5 dilution of PBS was added and 
incubated for 30 minutes. This antibody was prepared by KSVDL to the spike protein, and was 
generated using the hybridoma Z3-A-5. The plates were washed extensively with PBS. A 
secondary polyclonal with a fluorescent tag was added and incubated for 30 minutes. (Mouse 
monoclonal antibody (Fluorescein (FITC)-conjugated AffiniPure Goat Anti-Mouse IgG(H+L) by 
Jackson ImmunoResearch Laboratories Inc.) The plates were again washed with PBS and 50% 
Glycerol/PBS solution was added. The plates were then viewed using an epifluorescent 
microscope under 10X magnification. 
 Sequencing 
In this study we completed next generation sequencing (NGS) (Neill et al., 2014) of the 
full bovine coronavirus genome, using sequence independent single primer amplification 
(SISPA) methodology, to wholly assess the differences between enteric and respiratory 
isolates.(Djikeng et al., 2008) (Allander et al., 2001) We started off with 25 viral isolates that 
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were submitted as clinical samples. 9 of these isolates could not be sustained in cell culture and 
were unable to be sequenced. 5 of these isolates had CT values over 28 and were also unable to 
be sequenced.  
Samples were prepared by spinning the isolates at 10000 rpm for 5 minutes. The RNA 
was extracted using a column system (Qiagen MinElue Virus Spin Kit, Qiagen, Hilden, 
Germany). First strand synthesis was performed using the Life Technologies Superscript III First 
strand synthesis System. Directly following first strand synthesis was second strand synthesis 
using Affymetrix Sequenase 2.0 DNA Polymerase. Next cDNA was synthesized with random 
primers and then amplified via PCR. (Djikeng et al., 2008) The resulting PCR product was 
prepared according to Illumina’s Nextera XT DNA Sample Preparation Guide. This involved 
adding tags to random ends of the DNA, amplification, PCR cleanup, library normalization, and 
loading of the MiSeq Desktop Sequencer (Illumina). The raw data sequences that were generated 
with the MiSeq were aligned to BCU00735.2 in Gen Bank and processed in CLC database.  
 Serological Characterization Based on Different Viruses 
Field bovine serum samples submitted to KSVDL were divided into groups based on 
production, age, and gender to look at the prevalence of BCoV, age of exposure to BCoV, and 
potential titer differences against the unique genotypic strains of coronavirus (Table 2.1). Serum 
neutralization assays were used to measure antibody titers with in the samples. For the assays, 
96-well plates seeded with HCT-8 cells were maintained with MEM growth media for 4 days. 
The collected serums were diluted 1:20 in viral isolation media that contained 0.05% ttrypsin. 
The serum was then serially diluted 1:2 in sterile 96-well plates. The selected viruses were added 
to the diluted serum and incubated for 1 hour. The HCT-8 seeded plates were washed twice with 
sterile PBS then inoculated with the virus/serum media and incubated for 2 days. After 2 days 
the cells were washed with PBS and fixed in 80% aqueous acetone for 10 minutes. The 1:5 
dilution of Z3-A-5 hybridoma mouse monoclonal antibody was added and incubated for 30 
minutes. The plates were washed extensively with PBS. A dilution of 1:100 of secondary 
polyclonal Anti-Mouse IgG (Fluorescein (FITC)-conjugated AffiniPure Goat Anti-Mouse 
IgG(H+L) by Jackson ImmunoResearch Laboratories Inc.) was added and incubated for 30 
minutes. The plates were again washed with PBS and 50% Glycerol/PBS solution was added. 




Table 2-1 Field Serum Categories 
The bovine serums collected from KSVDL were split into groups based on age, gender, and 
production. Of the 147 samples, 10 samples were less than 1 year of age, 84 samples were 
between 1 and 2 years of age, and 53 samples were greater than 2 years of age. Of the 10 
samples that were less than 1 year of age, all were female and beef animals. Of the 84 samples 
that were between 1 and 2 years of age, 59 were female, 25 were male, 59 were beef and 25 were 
dairy. Lastly, of the samples that were over the age of 2, all were female, 43 were beef and 10 
were dairy. 
 
Age Female Male Total  Beef  Dairy Total 
 <1 
year 
10 0 10 10 0 10 
1-2 
years 
59 25 84 59 25 84 
>2 
years 
53 0 53 43 10 53 
Total 122 25 147 112 35 147 
 
 
Chapter 3 - Results 
 Phylogenetics 
Once NGS was completed, the reads of the nucleotide sequences of the 12 coronaviruses 
were processed and aligned using the Mebus strain (BCU000735) from GenBank as a reference 
template. Pairwise comparison of the viral sequence reads covered over 90%+ of the genome. 
One of the genomic reads, of virus (R7), covered less than 90% of the genome so it was not used 
in the analysis. From the represented sequences it was observed that the amino acids of the HE 
protein were conserved within the sequences and the spike protein was mostly conserved except 
for a few amino acid changes.  
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There were no nucleotide or amino acid changes that were exclusive to the enteric strains 
when compared with the respiratory strains. However, when aligned with a NCBI reference 
Mebus, several amino acid changes were apparent. The spike protein was 1363 amino acids long. 
Of those amino acids, 63 changes were found as illustrated in Table 3.2. Of the total amino acid 
changes in the spike protein, 49 were in the S1 subunit and 28 of these were significant 
alterations resulting in either hydrophobicity or charge modifications. The other 14 changes were 
located in the S2 subunit with only 6 significant alterations. This was expected since the S2 
subunit is more conserved. We also looked into the HE protein (Table 3.3) for its role in binding 
and found that there were 10 amino acid changes. Of those 10 changes, 4 were considered 
significant. These significant amino acid changes could be important because they have the 
ability to change the conformation of the protein which could lead to a change in receptor 
binding or could also lead to the binding of alternate receptors. 
Overall, no unanimous differences were observed between the enteric viruses and the 
respiratory viruses. Phylogenetic trees were constructed (bootstrapping value of 1000) using the 
alignments of the full genome, spike nucleotides, and HE nucleotides of the genome. During 
phylogenetic analysis of the full genome we can see that the Mebus stain is the most different 
from the other viruses sequenced. The rest of the viruses ultimately formed different clusters but 
the bootstrap value used in the analysis indicated no significant differences between them. When 
looking at the spike dendrogram and the HE dendrogram, similar results are observed. The 
Mebus strain is the most divergent from the set while the other viruses branch into separate 
groups without significant differences. (Figures 3.1, 3.2, and 3.3) 
 
Table 3-1 Sequencing Table 
This sequencing table shows the viruses that were sequenced. The first column is the virus 
identification. In the virus ID section, if it begins with an “R” it is a respiratory isolate and if it 
begins with an “E” then it is an enteric isolate. E5 is the Mebus vaccine strain. The second 
column is the accession number associated with the case from KSVDL it was selected from and 






Virus ID Accession Number CT Value 
R1 12-157760-2 24.18 
R2 13-149097 24.94 
R3 13-149008 23.95 
R4 12-155165 23.65 
R5 10-78481 25.86 
R8 13-149100 26.99 
R11 13-138077-3 19.29 
E1 14-007320 calf 1 25.59 
E2 14-007320 calf 2 24.94 
E4 11-129440 22.81 
E5 Bovine coronavirus Mebus strain 22.22 
 
 
Table 3-2 Spike Amino Acid Sequence 
The spike amino acid sequences were compared to a reference Mebus strain from NCBI. The 
first column refers to the position of the amino acid change within the spike protein. The next 
column to the right is the reference Mebus. The following columns refer to the virus ID that were 
sequenced. Any of the amino acids in white were changes in the amino acids from the reference 
Mebus. The significant change column refers to the type of change of the amino acid. The last 
column refers to the possibility that the amino acid change is a sequencing error. 
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Position NCBI Reference Mebus E5 R1 E1 E2 R4 R8 R3 R11 R5 R2 E4 Significant change Potential Sequencing Error
9 L L L L L L L no
11 M M T T T T T T T T T M hydrophobicity
24 V V V V V L V V V V V V no
28 D D D D D D D D D D D N charge
29 V I V V V V V V V V V V no
33 A A V V V V V V V V V V no
40 I I T T T T T T T T T T hydrophobicity
86 L L L L L L L L L L L S hydrophobicity yes
88 R R T R T T T T T T T T charge
100 I I T T T T T T T T T T hydrophobicity
115 K K D D D G D D D D D D charge
146 N N I I I I I I I I I I hydrophobicity
148 D D G G G G G G G G G G charge
154 L L F F F F F F F F F F no
169 H H N N N N H N N N N N no
173 H H N N N N N N N N N N no
174 P P S S S S S S S S S S hydrophobicity
179 K Q Q Q Q Q Q Q Q Q Q Q charge
243 S S S S S S S S S S S L hydrophobicity
248 L L M M M M M M M M M M no
253 S Y N N N N N N N N N N no
254 S S S S S S S S S S C S no
256 M M L L L L L L L L L L no
458 F S S S S S S S S S S S hydrophobicity
464 P P P P P P P P P P P L no
465 V V A A A A A A A A A A no
470 H H D D D D D D D D D D charge
484 S T T T T T T T T T T T no
492 D D G G G D D D D D D D charge
499 N N N N N S S S S S S S no
501 P P P P P S S S S S S S hydrophobicity
509 H H T T T N N N N N N N no
510 T T T T T T T T T T T I hydrophobicity
525 H H H Y Y H Y H Y H H H charge
528 A A A A A A A A A V A A no
531 N D D D D D D D D H D D charge
543 S S A A A A A A A A A A hydrophobicity
546 P P S S S S S S S S S S hydrophobicity
571 Y Y H H H H H H H H H H hydrophobicity
578 T T S S S S S S S S S S no
588 S S S S S S S S S A S S hydrophobicity
591 S S S S S S S S S S P S hydrophobicity
607 H H H H H H H H H H H Y charge
609 V V V V V V V V V V F V no
668 Y Y Y Y Y Y Y Y Y Y Y N no
717 L L L L L L L L F L L F no
729 S S S S S S S S S S R R charge
731 L L L L L L L R L L L L charge / hydrophobicity yes
769 A A S S S S S S S S S S hydrophobicity
778 T N N N N N N N N N N N no
965 V V E E E E E K E E E E charge / hydrophobicity
979 S S S S S S S S S N S S no
984 L W W W W W W W W W W W no
988 V A A A A A A A A A A A no
998 Y Y Y Y Y Y Y Y Y Y H Y no yes
999 R R R R R R R R R R H R charge yes
1026 D D G G G G G G G G G G charge
1100 V A A A A A A A A A A A no
1237 T T T T T T T T T T T I hydrophobicity
1241 H H P P P P P P P P P P charge / hydrophobicity
1275 D D D D D D Y D D D D D charge
1341 I I K K K K K K K K K K charge / hydrophobicity
1362 D D E E E E E E E E E E no




Table 3-3 HE Amino Acid Sequence 
The HE amino acid sequences were compared to a reference Mebus strain from NCBI. The first 
column refers to the position of the amino acid change within the HE protein. The next column 
to the right is the reference Mebus. The following columns refer to the virus ID that were 
sequenced. Any of the amino acids in white were changes in the amino acids from the reference 






Position NCBI Referece Mebus E5 E1 E2 E4 R2 R3 R4 R5 R8 R1 R11 Significant change
5 L L P P P P P P P P P P no
49 N N T T T T T T T T T T no
66 D D G G G G G G G G G G charge
103 V L V V V V V V V V V V no
147 N N N N N N N N N N N S no
309 P P P P P P P P P P L P no
367 S S P P P P P P P P P P hydrophobicity
376 D G D D D D D D D D D D charge
392 L L I I I I I I I I I I no
400 G G G G G G G G G G G V hydrophobicity




Figure 3-1 Bovine Coronavirus Whole Genome Phylogenetic Tree 
The following dendogram is based on the whole genome sequences with a bootstrapping value of 





Figure 3-2 Bovine Coronavirus Spike Phylogenetic Tree 
The following dendogram is based on the spike protein sequences with a bootstrapping value of 








Figure 3-3 Bovine Coronavirus Hemagglutinin Esterase Phylogenetic Tree 
The following dendogram is based on the HE protein sequences with a bootstrapping value of 







 Virus Selection 
The viruses were selected based on the phylogenetic analysis from sequencing. Each 
virus’s ability to grow and be maintained in cell culture also played a role in selection. HCT-8 
cells were used as the primary cell line for growth. The selected viruses contain 3 respiratory 
isolates (10-78481, 13-149100, and 13-149008) and 2 enteric isolates (Mebus, 14-007320 calf 1).  
 Virus Specific Seroprevelence 
To determine if the serum antibodies would have a diverse reaction to the selected 
viruses, serum neutralization assays were performed. Initial serosurveillance were carried out 
using 147 collected serum from the KSVDL against the selected viruses. The results as listed in 
Figure 3.4 show the individual serum samples against each virus. Only 12% of the serums 
showed a 4-fold difference in the neutralizing ability to at least one of the viruses indicating that, 
for the most part, the serum antibodies reacted similarly among the viruses. For the viruses that 
did have a 4-fold difference, Table 3.4 shows the analysis between the different groups and the 
respiratory and enteric viruses. All of the samples that were significant were female and 83% 
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were beef animals. Looking at the virus breakdown shows that 13-149008 was high in 5 of those 
samples and low in 2 samples. 10-78481 was high in 7 of the samples and low in 2 samples. 
Interestingly, the Mebus strain was only high in 2 sample and low in 10 of the samples. The 
other enteric sample, 14-007320, was high in 6 samples and low in 3 samples. The last 
respiratory sample, 13-149100, was high in 5 of the samples and low in 5 of the samples. This 
concludes that there is no real pattern of certain viruses always being high or low. 
When it comes to the overall group breakdown, the biggest difference was observed 
between age groups. Animals <1 year of age showed the lowest titers followed by 1-2 years of 
age and, lastly, > 2 years of age. The analysis of the male and female groups showed males to 
have lower titers to the viruses than females. This is not conclusive, however, because of the low 
number of sample numbers for the males. The difference could also be due to the low age of the 
males as compared to the females. Examination of dairy versus beef groups indicates that there is 
no significant difference between the two. 
 
 
Figure 3-4 Individual Serum Sample for Serum Surveillance SN assays 
The individual samples from the virus seroprevelence assays were graphed on a log base 10 
scale. Each serum sample was tested against the 5 viruses. Each virus is color coded and ties 
back to the selected viruses and is arranged in the table below. 
Virus ID Accession Number 
V1 13-149008 
V2 10-78481 
V3 BCoV Mebus strain 












Table 3-4 Breakdown of Significant Difference in Serum Surveillance Assays 
A breakdown of the 12% of the viruses that showed a 4 fold difference in serum antibody titer to 
at least two different viruses. The antibody titer is based on a log 10 scale. The low antibody titer 
virus is shown in green and the high antibody titer virus is shown in red. The groups category 
shows the production type (B=Beef, D=Dairy), gender (F=female, M=male) and the age of the 
animal in years. The viruses are labeled with a “R” for respiratory virus or an “E” for an enteric 
virus, followed by the KSVDL accession number or name. 
 
Groups Serum Number R: 13-149008 R: 10-78481 E: BCoV Mebus E: 14-007320 calf 1 R: 13-149100 
B, F, 0.75y 26 40 20 20 12 40 
B, F, 0.75y 29 140 130 60 70 240 
B, F, 2y 54 640 500 140 240 160 
B, F, 5 y 59 3200 1280 1280 320 1760 
B, F, Adult 61 280 740 160 480 200 
B, F, Adult 62 640 740 200 340 200 
B, F, Adult 64 2240 1280 400 800 560 
D, F, 1.6y 65 800 960 320 560 200 
D, F, 4.5y 70 640 1260 280 560 320 
D, F, 4.5y 71 960 2000 400 520 400 
B, F, 6.5y 80 50 130 35 240 180 
B, F, 6.5y 82 90 230 50 200 200 
B, F, 1.5y 101 160 600 240 1080 540 
B, F, 8y 107 400 560 480 1680 1120 
B, F, 1.5y 111 1920 560 1280 2880 480 
B, F, 0.5y 126 1600 480 320 320 480 
B, F, 2y 133 1920 320 2240 2560 960 















Chapter 4 - Discussion and Conclusion 
In the past BCoV was associated primarily with enteric disease in calves but more 
recently, it has also been isolated in adult cattle with respiratory disease. This raises the question: 
Are the respiratory coronavirus isolates and the enteric coronavirus isolates different and how do 
they compare to the vaccine strain? This study evaluates the diversity of the BCoV isolates via 
sequencing and serum neutralization assays. 
 Sequencing 
In this study, 11 coronavirus isolates were sequenced using Next Generation sequencing. 
The full genomes were analyzed with a focus on the spike and hemagglutinin esterase segments. 
Isolates were selected based on the tissue they were isolated from, their ability to grow in cell 
culture and the cycle threshold (CT) values based on RT-PCR that were determined by KSVDL. 
The virus isolates that were to be sequenced demonstrated that there is slight genomic difference 
between the different respiratory and enteric isolates based on the phylogenetic tree group 
clustering.  
Also, looking at the amino acids of each sequence showed that there are few differences 
in the structural proteins. Spike had the most amino acid changes followed by HE, which is to be 
expected since these regions are not very conserved. By not being as conserved they have more 
mutations that could lead to a change in the structure and would allow the virus to bind to 
different receptors. For the more conserved regions, the envelope protein had two amino acid 
changes but neither had a significant change in charge or hydrophobicity. The membrane protein 
also had two amino acid changes with both being a significant change. Lastly the nucleocapsid 
had one amino acid change that was significant. Because these regions are more conserved we 
expected less change. They also will not play as big of a role in virus diversity since they don’t 
contribute to attachment and entry of the virus. 
 Assays 
To further investigate the isolate differences, serum neutralization assays were 
performed. Analysis of the SN assays showed that only 12% of the viruses showed a greater than 
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four-fold increase between two viruses. From what we can analyze, there is not a significant 
difference between the neutralization of the enteric and respiratory isolates. The serum 
neutralization assays measure the amount of neutralizing antibody within the serum. It is hard to 
make a full analysis because the vaccination history and background of the animals is unknown. 
Also the animal might be making cross protective antibodies. 
 There was a plan to make a killed vaccine with the selected isolates and inject them into 
guinea pigs to create monospecific antisera. The antisera would then be put against the other 
viruses to see if the sera against the respiratory virus could neutralize the enteric virus and vice 
versa. However, we were unable to complete this portion based on an inability to grow the virus 
to a high enough titer for vaccine development. 
 Future work 
For a better understanding of the virus’s receptor attachment, additional investigation 
needs to be done on the location of these amino acids. If theses amino acids are on the surface of 
the protein, then there might be a difference in the conformation of the proteins. Changes in the 
protein conformation allows the virus to attach to different receptors on cells or to not bind at all.  
Also, an additional study can be done, using an animal model to examine the neutralizing 
capabilities of monospecific serum to the different isolates. This study could revel valuable 
information on the neutralizing capabilities of monospecific serum against the different viruses. 
It would also be interesting to test generate monospecific serum to the Mebus vaccine strain to 
see if it has the greatest neutralizing capabilities.  
With coronavirus outbreaks on the rise, it is more important to remain diligent in our 
research to find out more about the virus. Continuing to strive to understand more about the 
mechanisms of replication and how different factors such as virulence and tropism play a role in 
how the virus interacts with the host’s immune response. This will further help the research 
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